Acute encephalitis with refractory, repetitive partial seizures: Pathological findings and a new therapeutic approach

Yuko Sato1, Yurika Numata-Uematsu1, Mitsugu Uematsu1

  • 1Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.

Brain & Development
|February 25, 2016
PubMed

Insights

This case report details a severe form of acute encephalitis with refractory, repetitive partial seizures (AERRPS). Tacrolimus effectively managed seizures by targeting T-cell and microglia responses, offering a new therapeutic avenue.

Area of Science:

  • Neuroimmunology
  • Epileptology

Background:

  • Acute encephalitis with refractory, repetitive partial seizures (AERRPS) presents with severe, prolonged seizures and fever.
  • Standard treatments and even surgical intervention were ineffective in a severe pediatric case.

Observation:

  • A pediatric patient with severe AERRPS exhibited right-sided partial seizures, requiring prolonged intensive care.
  • Cerebrospinal fluid analysis revealed elevated protein, proinflammatory cytokines, and anti-glutamate receptor ε2 antibodies.
  • Pathology showed significant microglial and T-cell infiltration with spongiosis in the affected brain region.

Findings:

  • Tacrolimus treatment led to significant amelioration of daily seizure clusters.
  • Seizure recurrence upon tacrolimus discontinuation highlights its therapeutic role.
  • This report provides the first pathological insights into AERRPS and demonstrates tacrolimus efficacy.

Implications:

  • Tacrolimus shows promise as an effective immunosuppressive therapy for severe AERRPS.
  • Targeting T-cell and microglia-mediated inflammation may be crucial for managing AERRPS.
  • This case expands therapeutic options for refractory epilepsy associated with autoimmune encephalitis.